Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Vanda PharmaceuticalsAtrecaEndonovo TherapeuticsKadmonUrogen Pharma
SymbolNASDAQ:VNDANASDAQ:BCELOTCMKTS:ENDVNYSE:KDMNNASDAQ:URGN
Price Information
Current Price$9.16$15.34$0.17$3.99$17.70
52 Week RangeHoldBuyN/ABuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyN/ABuyBuy
Consensus Price Target$16.00$24.41N/A$13.25$48.83
% Upside from Price Target74.67% upside59.11% upsideN/A232.08% upside175.89% upside
Trade Information
Market Cap$501.61 million$440.70 million$165.42 million$648.64 million$368.41 million
Beta0.45N/A2.122.071.32
Average Volume1,068,399319,793169,1422,873,625251,609
Sales & Book Value
Annual Revenue$227.19 millionN/A$80,000.00$5.09 million$20,000.00
Price / Sales2.16N/A2,067.76125.2318,496.50
Cashflow$2.12 per shareN/AN/AN/AN/A
Price / Cash4.32N/AN/AN/AN/A
Book Value$7.70 per share$6.68 per share($0.03) per share$0.95 per share$8.63 per share
Price / Book1.19N/A-5.504.202.05
Profitability
Net Income$115.55 million$-67,480,000.00$-6,440,000.00$-61,370,000.00$-105,150,000.00
EPS$2.11($4.26)N/A($0.74)($5.12)
Trailing P/E Ratio4.32N/A0.00N/AN/A
Forward P/E Ratio17.96N/A∞6.44N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins50.86%N/A-5,033.33%-1,204.47%N/A
Return on Equity (ROE)33.33%N/AN/A-110.70%-49.16%
Return on Assets (ROA)27.48%N/A-264.21%-48.18%-45.73%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.16%N/A
Current Ratio5.95%22.16%N/A6.42%7.63%
Quick Ratio5.93%22.16%N/A6.40%7.63%
Ownership Information
Institutional Ownership Percentage98.54%60.19%N/A80.93%67.29%
Insider Ownership Percentage8.20%N/A5.61%2.85%10.50%
Miscellaneous
Employees27085N/A11670
Shares Outstanding53.65 million28.07 million1.00 billion159.76 million20.90 million
Next Earnings Date5/6/2020 (Estimated)6/10/2020 (Estimated)4/20/2020 (Estimated)5/14/2020 (Estimated)5/14/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel